Lanean...

FDG- and amyloid-PET in Alzheimer’s disease: is the whole greater than the sum of the parts?

The development of prevention therapies for Alzheimer’s disease (AD) would greatly benefit from biomarkers that are sensitive to subtle brain changes occurring prior to the onset of clinical symptoms, when the potential for preservation of function is at the greatest. In vivo brain imaging is a prom...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mosconi, L., McHugh, P. F.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3290913/
https://ncbi.nlm.nih.gov/pubmed/21532539
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!